Abstract:Non-Maximum Suppression (NMS) remains a key post-processing step in many real-time object detection pipelines, but it can introduce latency variation and deployment complexity in resource-constrained settings. Recent NMS-free designs such as YOLO26 aim to reduce this dependence through end-to-end detection, yet their performance relative to established NMS-based models such as YOLOv8 remains underexplored beyond standard benchmarks. This paper compares YOLOv8 and YOLO26 on Pascal VOC and VisDrone, representing general object detection and dense aerial small-object detection, respectively. Both model families are evaluated across five scales using accuracy, localization, model size, GFLOPs, and CPU/GPU latency. Results show that YOLO26 achieves stronger detection performance and lower model complexity on Pascal VOC across most scales, while the performance gap narrows on VisDrone, where both models struggle with dense small targets. YOLOv8 remains competitive in GPU latency, showing that NMS-free design does not guarantee universal deployment superiority. Overall, the study shows that detector selection depends on dataset characteristics, object scale, model capacity, and hardware constraints.
Abstract:A brain tumor is a medical disorder faced by individuals of all demographics. Medically, it is described as the spread of non-essential cells close to or throughout the brain. Symptoms of this ailment include headaches, seizures, and sensory changes. This research explores two main categories of brain tumors: benign and malignant. Benign spreads steadily, and malignant expresses growth, making it dangerous. Early identification of brain tumors is a crucial factor for the survival of patients. This research provides a state-of-the-art approach to the early identification of tumors within the brain. We implemented the SegResNet architecture, a widely adopted architecture for three-dimensional segmentation, and trained it using the automatic multi-precision method. We incorporated the dice loss function and dice metric for evaluating the model. We got a dice score of 0.84. For the tumor core, we got a dice score of 0.84; for the whole tumor, 0.90; and for the enhanced tumor, we got a score of 0.79.